Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$215.77
Market cap
$21.3B
P/E Ratio
49.04
Dividend/share
$2.18
EPS
$4.4
Enterprise value
$23.53B
Steris Corporation is an American Irish-domiciled medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, but has been
Highlights
STERIS's debt has decreased by 34% YoY and by 3.4% from the previous quarter
STE's P/E is 26% below its 5-year quarterly average of 65.9 and 5% below its last 4 quarters average of 51.6
The company's net income fell by 21% YoY but it rose by 9% QoQ
The company's EPS fell by 20% YoY but it rose by 9% QoQ
Key stats
What are the main financial stats of STE
Market
Valuations
Earnings
Shares outstanding
98.71M
Market cap
$21.3B
Enterprise value
$23.53B
Price to earnings (P/E)
49.04
Price to book (P/B)
3.23
Price to sales (P/S)
4.16
EV/EBIT
32.66
EV/EBITDA
19.23
EV/Sales
4.59
Revenue
$5.12B
EBIT
$720.32M
EBITDA
$1.22B
Free cash flow
$680.13M
Per share
Balance sheet
Liquidity
EPS
$4.4
Free cash flow per share
$6.9
Book value per share
$66.86
Revenue per share
$51.92
TBVPS
$41.44
Total assets
$10.24B
Total liabilities
$3.63B
Debt
$2.4B
Equity
$6.59B
Working capital
$1.13B
Debt to equity
0.36
Current ratio
2.41
Quick ratio
1.36
Net debt/EBITDA
1.82
Margins
Efficiency
Dividend
EBITDA margin
23.9%
Gross margin
43%
Net margin
8.5%
Operating margin
17.3%
Return on assets
4.1%
Return on equity
6.8%
Return on invested capital
11.6%
Return on capital employed
7.6%
Return on sales
14.1%
Dividend yield
1.01%
DPS
$2.18
Payout ratio
49.5%
STE stock price
How has the STERIS stock price performed over time
Intraday
1.66%
1 week
-2.45%
1 month
-3.83%
1 year
7.25%
YTD
-1.86%
QTD
-11.04%
Financial performance
How have STERIS's revenue and profit performed over time
Revenue
$5.12B
Gross profit
$2.2B
Operating income
$885.38M
Net income
$434.8M
Gross margin
43%
Net margin
8.5%
STE's operating margin is down by 40% year-on-year
STE's operating income is down by 33% YoY but it is up by 3.3% from the previous quarter
STERIS's net margin has decreased by 29% YoY but it has increased by 6% from the previous quarter
The company's net income fell by 21% YoY but it rose by 9% QoQ
Growth
What is STERIS's growth rate over time
Valuation
What is STERIS stock price valuation
P/E
49.04
P/B
3.23
P/S
4.16
EV/EBIT
32.66
EV/EBITDA
19.23
EV/Sales
4.59
STE's P/E is 26% below its 5-year quarterly average of 65.9 and 5% below its last 4 quarters average of 51.6
The company's EPS fell by 20% YoY but it rose by 9% QoQ
STE's P/B is 8% below its 5-year quarterly average of 3.5 and 8% below its last 4 quarters average of 3.5
The company's equity rose by 7% YoY and by 3.8% QoQ
The P/S is 11% below the 5-year quarterly average of 4.7 and 8% below the last 4 quarters average of 4.5
The revenue has grown by 11% YoY
Efficiency
How efficient is STERIS business performance
The company's return on sales fell by 25% YoY but it rose by 2.2% QoQ
The ROE has decreased by 24% YoY but it has increased by 8% from the previous quarter
STERIS's ROA has decreased by 18% YoY but it has increased by 14% from the previous quarter
STERIS's ROIC has decreased by 13% YoY but it has increased by 8% from the previous quarter
Dividends
What is STE's dividend history
DPS
$2.18
Dividend yield
1.01%
Payout ratio
49.5%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did STERIS financials performed over time
The total assets is 182% more than the total liabilities
STE's total liabilities is down by 29% year-on-year and by 2.8% since the previous quarter
The total assets has contracted by 9% YoY
STERIS's debt is 64% less than its equity
STE's debt to equity is down by 39% year-on-year and by 8% since the previous quarter
STERIS's debt has decreased by 34% YoY and by 3.4% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.